COMMERCIALML
LIVE

Serial Number

98773003

Owner

EntityRisk, Inc.

Attorney

Tracy Wells

First Use Date

May 5, 2024

Filing Date

Sep 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

COMMERCIALML Trademark

Serial Number: 98773003

COMMERCIALML is a trademark filed by EntityRisk, Inc. on September 26, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

EntityRisk, Inc. (6 trademarks)

300 Carnegie Center Suite 150
Princeton, NJ 08540

Entity Type: 03

Trademark Details

Filing Date

September 26, 2024

Registration Date

Not Registered

First Use Anywhere

May 5, 2024

First Use in Commerce

May 5, 2024

Goods & Services

Design, development, and implementation of software for predicting asset values, determining pricing, evidence-generation, contracting by utilizing a pricing and generalized value module and commercial due diligence module, building financial recommendations based on clinical evidence of benefit and risk, expediting value assessment, and providing a qualitative evidence based financial approach to support decisions about pricing, evidence generation and contracting; Providing an interactive website featuring technology that allows users to enter, access, and synthesize information and generate reports for use in consulting with executives and businesses; Software as a service (SAAS) featuring software for predicting business asset values, determining pricing, evidence generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module.

Computer software platforms, downloadable, for predicting asset values, determining pricing, evidence-generation, and contracting by utilizing a pricing and generalized value module and commercial due diligence module; Computer software platforms, downloadable, for use in building financial recommendations based on clinical evidence of benefit and risk, expediting value assessment, and providing a qualitative evidence based financial approach to support decisions about pricing, evidence generation and contracting; Computer software platforms, downloadable, for use in forecasting and quantifying the commercial revenue opportunity and downside risks under all efficacy and marketplace competition scenarios to support go-to-market pricing and value-based care strategies

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 2, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 2, 2026 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 2, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 2, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 2, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2025 NWOS
NEW APPLICATION ENTERED
Sep 27, 2024 NWAP